CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 80 filers reported holding CRINETICS PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,368 | +103.1% | 113,282 | +23.0% | 0.00% | +100.0% |
| Q2 2023 | $1,658 | -5.5% | 92,093 | -15.7% | 0.00% | 0.0% |
| Q1 2023 | $1,755 | +39.3% | 109,273 | +58.7% | 0.00% | 0.0% |
| Q4 2022 | $1,260 | -99.9% | 68,843 | +36.0% | 0.00% | 0.0% |
| Q3 2022 | $994,000 | +1225.3% | 50,605 | +1152.0% | 0.00% | – |
| Q2 2022 | $75,000 | -63.9% | 4,042 | -57.4% | 0.00% | – |
| Q1 2022 | $208,000 | -93.7% | 9,486 | -91.8% | 0.00% | -100.0% |
| Q4 2021 | $3,284,000 | +809.7% | 115,574 | +574.5% | 0.00% | – |
| Q3 2021 | $361,000 | +27.6% | 17,135 | +13.8% | 0.00% | – |
| Q2 2021 | $283,000 | -24.5% | 15,061 | -38.7% | 0.00% | – |
| Q1 2021 | $375,000 | +145.1% | 24,582 | +125.4% | 0.00% | – |
| Q4 2020 | $153,000 | -31.4% | 10,908 | -23.4% | 0.00% | – |
| Q3 2020 | $223,000 | -24.4% | 14,241 | -15.2% | 0.00% | – |
| Q2 2020 | $295,000 | +446.3% | 16,788 | +358.7% | 0.00% | – |
| Q1 2020 | $54,000 | -80.8% | 3,660 | -67.3% | 0.00% | – |
| Q4 2019 | $281,000 | +212.2% | 11,198 | +87.2% | 0.00% | – |
| Q3 2019 | $90,000 | -58.3% | 5,983 | -30.7% | 0.00% | – |
| Q2 2019 | $216,000 | +78.5% | 8,633 | +62.2% | 0.00% | – |
| Q1 2019 | $121,000 | +61.3% | 5,322 | +104.1% | 0.00% | – |
| Q3 2018 | $75,000 | – | 2,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,375,169 | $84,379,000 | 7.91% |
| RA Capital Management | 1,875,209 | $46,880,000 | 2.52% |
| Perceptive Advisors | 2,587,953 | $64,698,000 | 1.48% |
| New Leaf Venture Partners, L.L.C. | 167,700 | $4,193,000 | 1.12% |
| Orbimed Advisors | 2,039,282 | $50,982,000 | 0.79% |
| Eventide Asset Management | 803,839 | $20,096,000 | 0.61% |
| Novo Holdings A/S | 135,009 | $3,375,000 | 0.47% |
| Opaleye Management Inc. | 36,000 | $900,000 | 0.27% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 490,000 | $12,250,000 | 0.03% |
| Baker Brothers Advisors | 132,985 | $3,325,000 | 0.02% |